Avatar for Phyteau

Natural technologies for diabetes, obesity and metabolic syndrome.

Natural technologies for diabetes, obesity and metabolic syndrome.

Developing an innovative new approach for diabetes, obesity, prediabetes and related metabolic conditions. Our completely safe agents work entirely in the gut where they trigger cellular receptors causing the release therapeutic levels of key metabolic hormones. Using science to harness the power of Nature and your own hormones to let you take control of bloodsugar, metabolism, appetite and food intake with our safe, effective and affordable, first-of-its-kind treatments.

Compared to existing state-of-the art therapies, we eliminate systemic side-effects, are safe and effective, and much more affordable. Our agents include safe & natural compounds that fully leverage our mechanism allowing us to pursue multiple markets - including nutraceuticals, targeted diabetic, diet, medical & functional foods, as well as pharmaceuticals.

Phyteau was in the RebelBio biotech accelerator (UK/Ireland) and the Plug and Play accelerator (Silicon Valley).
Professor of Medicine, UCLA. Director of basic and translational pancreatic research at Cedars-Sinai Medical Center.
CEO, Phyteau, Inc. - nutraceutical & pharma tech. Founder, Startup Santa Fe. Former management consultant, McKinsey & Booz Allen; economist, corp planner

Phyteau hasn't added any jobs yet

Get notified when Phyteau posts new jobs.

See similar jobs